Skip to main content
Market intelligence
ROIVHealthcare

Roivant Sciences Ltd insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Melissa B EpperlyCorporate insiderSale17,750$36.10$640,860
Sep 30, 2026Eric VenkerPresident & Immunovant CEOSale200,000$36.62$7,324,000
Sep 15, 2026Melissa B EpperlyCorporate insiderSale4,938$39.74$196,230